It is not always easy to find a CDMO that brings together all the cutting-edge technologies needed to develop medical devices based on hyaluronan or other biopolymers. It is because we know that it is complex, that we have chosen to put at your disposal in one place all the necessary technical and human skills.

Technology Platform

Technology Platform:

We have the plurality of formulation, homogenization, chemical modification, degassing, syringe filling and sterilization technologies that are required to move from prototyping to first series production.

Syrhatec - Formulation

Our staff:

They are experts in their field, who work as a team to ensure a high level of performance within controlled deadlines. We constantly provide them with training in the latest techniques.

Syrhatech - assets

Our assets:

Know-how in the characterization of the various parameters typical of hydrogels, including viscosity, elasticity, resistance to degradation, ease of injection, etc.
We measure and adjust the interdependence of all these specific aspects to achieve the desired effect. We ensure the innovative nature of the proposed solutions.
Of course, we also take into account long-term stability (real-time and accelerated stability; resistance to enzymatic and free-radical degradation; determination of molecular weight and degree of modification).
In parallel with experiments, we carry out analytics and interpretation of results, problem solving, and provide the necessary elements to defend our clients’ patents.


Our solutions :

SyrHAtech perfectly masters the selection of relevant factors such as rheological properties (viscosity, elastic modulus G’, viscus modulus G”, tangent delta), molecular structure, resistance to degradation, injection force as well as concentration and degree of crosslinking to support savvy and efficient development.

Do you have a project? We put our expertise at your service, to achieve it from A to Z.

Explore our environment

  • Company

    SyrHATech goes to CPHI Barcelona – from 10/24 to 10/26

    The CPHI (Convention on Pharmaceutical Ingredients) is the reference event for the pharmaceutical industry. Itinerant…

    CPHI Barcelona 2023
  • Company

    Inauguration of Syrhatech’s new premises in Geneva

    The Syrhatech team was delighted to share a convivial moment on its terrace on the…

    Inauguration of Syrhatech's new premises in Geneva
  • Company

    Development of a specific syringe for wrinkle filler

    Our customer contacts us to validate the design of a syringe made of plastic by…

  • Company

    Development of an innovative gel with very high concentration

    Our client contacts us to industrialize a new manufacturing technique, compatible with the objectives of…

  • Company

    Technology transfer

    Our team relies on its many years of experience and past successes, to prepare and…

    Syrhatech - technology transfer
  • Company

    Development of a cross-linked HA formulation containing peptides

    At the request of our customer, this cross-linked HA product incorporates peptides for various therapeutic…

    Syrhatech - Value added technology
  • Company

    Development of a cross-linked hydrogel similar to an existing product

    Reverse engineering and formulation of cross-linked HA for specific (non-aesthetic) applications, and development of steam…

  • Company

    Formulation of a new polymer

    Technology transfer and development of a manufacturing process for a polysaccharide other than hyaluronic acid…

    Syrhatech - Who are we ?